The Fish Oil Market Is Not One Product
When a cardiologist recommends fish oil, or when a meta-analysis concludes fish oil "does not reduce cardiovascular events," the product being referenced is almost always standard EPA/DHA fish oil — typically a two-fatty-acid concentrate. Full-spectrum omega-3 products derived from whole fish include a broader range of fatty acids, and the research on one does not automatically apply to the other.
This article examines the difference between standard fish oil concentrates and full-spectrum omega-3 products. No therapeutic claims are made. Not evaluated by the FDA.
The 8 Omega-3 Fatty Acids in Fish
| Omega-3 Fatty Acid | Abbreviation | In standard fish oil? | In full-spectrum? |
|---|---|---|---|
| Eicosapentaenoic acid | EPA (20:5) | Yes | Yes |
| Docosahexaenoic acid | DHA (22:6) | Yes | Yes |
| Docosapentaenoic acid | DPA (22:5) | Rarely | Yes |
| Eicosatetraenoic acid | ETA (20:4) | No | Yes |
| Stearidonic acid | SDA (18:4) | No | Yes |
| Heneicosapentaenoic acid | HPA (21:5) | No | Yes |
| Tetracosapentaenoic acid | TPA (24:5) | No | Yes |
| Tetracosahexaenoic acid | THA (24:6) | No | Yes |
Why This Distinction Matters for Research Interpretation
The STRENGTH trial (2020) and subsequent meta-analyses found that high-dose EPA/DHA corn oil placebos did not reduce cardiovascular events versus omega-3 treatment. However, the REDUCE-IT trial using high-dose pure EPA (icosapentaenoic acid ethyl ester) showed significant cardiovascular benefit. The difference between these outcomes reflects the complexity of omega-3 biology — not all omega-3 interventions are equivalent.
When the ACC or AHA updates recommendations on fish oil, the evidence base is primarily from studies using standard EPA+DHA concentrates in ethyl ester form. Full-spectrum fish oil in natural triglyceride form represents a different formulation with a different fatty acid profile, and should not be assumed equivalent to the product studied.
Key Distinctions When Evaluating Fish Oil Research
- Fatty acid spectrum: Standard (EPA+DHA only) vs full-spectrum (8 omega-3s)
- Delivery form: Ethyl ester vs natural triglyceride — absorption differs significantly
- Dose: Low-dose (1g/day) vs high-dose (4g/day) studies show different outcomes
- Population: Primary prevention vs secondary prevention studies are not directly comparable
- Duration: Short-term supplement studies often do not reflect long-term dietary intake patterns
NeoLife Omega 3 Plus: Natural Triglyceride Form
NeoLife Omega 3 Plus delivers omega-3 fatty acids in natural triglyceride form — the same structural form as in whole fish — rather than the ethyl ester form used in many research studies and mass-market products. Research shows triglyceride form absorbs up to 70% more effectively than ethyl ester form, particularly without co-ingestion of dietary fat. For a detailed breakdown of purity testing and delivery form, see the Omega 3 Plus pillar page.
Frequently Asked Questions
Why do some studies show fish oil doesn't work?
Most negative fish oil studies used low doses (1g/day) of ethyl ester EPA+DHA concentrate. The REDUCE-IT trial using high-dose pure EPA showed significant cardiovascular benefit. Product form, dose, and fatty acid profile all affect outcomes — a negative result from one formulation does not apply to all omega-3 products.
What is DPA and why does it matter?
DPA (docosapentaenoic acid, 22:5 n-3) is an intermediate between EPA and DHA in the omega-3 elongation pathway. Emerging research suggests DPA may have independent biological activity including anti-inflammatory properties and a role in platelet function. Standard fish oil concentrates typically do not include DPA.
* Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.